You are here

Article info

Article menu
Download PDFPDF
Inflammatory bowel disease
Original research
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab

Authors

  • Nicholas A Kennedy Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK PubMed articlesGoogle scholar articles
  • James R Goodhand Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK PubMed articlesGoogle scholar articles
  • Claire Bewshea Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK PubMed articlesGoogle scholar articles
  • Rachel Nice Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK Department of Biochemistry, Exeter Clinical Laboratory International, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK PubMed articlesGoogle scholar articles
  • Desmond Chee Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK PubMed articlesGoogle scholar articles
  • Simeng Lin Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK PubMed articlesGoogle scholar articles
  • Neil Chanchlani Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK PubMed articlesGoogle scholar articles
  • Jeffrey Butterworth Department of Gastroenterology, Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, UK PubMed articlesGoogle scholar articles
  • Rachel Cooney Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK PubMed articlesGoogle scholar articles
  • Nicholas M Croft Department of Paediatric Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK PubMed articlesGoogle scholar articles
  • Ailsa L Hart Department of Gastroenterology, St Mark's Hospital and Academic Institute, Harrow, London, UK PubMed articlesGoogle scholar articles
  • Peter M Irving Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK School of Immunology & Microbial Sciences, King's College London, London, UK PubMed articlesGoogle scholar articles
  • Klaartje B Kok Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK Department of Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Christopher A Lamb Department of Gastroenterology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles
  • Jimmy K Limdi Department of Gastroenterology, Pennine Acute Hospitals NHS Trust, Manchester, UK Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Jonathan Macdonald Department of Gastroenterology, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK PubMed articlesGoogle scholar articles
  • Dermot PB McGovern F. Widjaja Foundation Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Shameer J Mehta Department of Gastroenterology, University College London Hospitals NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Charles D Murray Department of Gastroenterology, Royal Free London NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Kamal V Patel Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Richard CG Pollok Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London, UK Institute for Infection and Immunity, University of London, London, UK PubMed articlesGoogle scholar articles
  • Timothy Raine Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK PubMed articlesGoogle scholar articles
  • Richard K Russell Department of Paediatric Gastroenterology, Royal Hospital for Sick Children, NHS Lothian, Edinburgh, UK PubMed articlesGoogle scholar articles
  • Christian P Selinger Department of Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK PubMed articlesGoogle scholar articles
  • Philip J Smith Department of Gastroenterology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK PubMed articlesGoogle scholar articles
  • Jack Bowden Medical School, University of Exeter, Exeter, UK PubMed articlesGoogle scholar articles
  • Timothy J McDonald Department of Biochemistry, Exeter Clinical Laboratory International, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK PubMed articlesGoogle scholar articles
  • Charlie W Lees Department of Gastroenterology, Western General Hospital, NHS Lothian, Edinburgh, UK Institute of Genetic and Molecular Medicine, University of Edinburgh, Edinburgh, UK PubMed articlesGoogle scholar articles
  • Shaji Sebastian Department of Gastroenterology, Hull University Teaching Hospitals NHS Trust, Hull, UK PubMed articlesGoogle scholar articles
  • Nicholas Powell Division of Digestive Diseases, Faculty of Medicine, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK PubMed articlesGoogle scholar articles
  • Tariq Ahmad Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK PubMed articlesGoogle scholar articles
  • Contributors to the CLARITY IBD study
    Google scholar articles
  1. Correspondence to Dr Tariq Ahmad, Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, Devon, UK; tariq.ahmad1{at}nhs.net
View Full Text

Citation

Kennedy NA, Goodhand JR, Bewshea C Contributors to the CLARITY IBD study, et al
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
Gut 2021;70:865-875.

Publication history

  • Received February 10, 2021
  • Revised February 17, 2021
  • Accepted February 18, 2021
  • First published March 22, 2021.
Online issue publication 
April 07, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage